EUVIMEDEUVIMED entdecken
Open Access · CC BYNC 4.0

Real-World Effectiveness and Safety of Inclisiran Monotherapy in Chinese Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia

Xiao-Ya Li, Ming-Yao Yang, Yu Guo, Jin-Jin Mou, Hua Tao, Aaron Soon, Qin-Qin Zhou, Chen-Jie Shi, Zhen Li, Qi Zhang, Helen Zhang

Research in Clinical Pharmacy · 30.06.2026 · 4 (1) · 24-33

DOI: 10.59931/rcp.26.0005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Clinical Pharmacy, erschienen am 30.06.2026. Verfasst von Xiao-Ya Li und 10 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BYNC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, X., Yang, M., Guo, Y., Mou, J., Tao, H., Soon, A., Zhou, Q., Shi, C., Li, Z., Zhang, Q., & Zhang, H. (2026). Real-World Effectiveness and Safety of Inclisiran Monotherapy in Chinese Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia. Research in Clinical Pharmacy, 4(1), 24-33. https://doi.org/10.59931/rcp.26.0005

Vancouver

Li X, Yang M, Guo Y, Mou J, Tao H, Soon A, et al. Real-World Effectiveness and Safety of Inclisiran Monotherapy in Chinese Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia. Research in Clinical Pharmacy. 2026;4(1):24-33. doi:10.59931/rcp.26.0005

BibTeX
@article{Li2026,
  author = {Li, Xiao-Ya and Yang, Ming-Yao and Guo, Yu and Mou, Jin-Jin and Tao, Hua and Soon, Aaron and Zhou, Qin-Qin and Shi, Chen-Jie and Li, Zhen and Zhang, Qi and Zhang, Helen},
  title = {Real-World Effectiveness and Safety of Inclisiran Monotherapy in Chinese Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia},
  journal = {Research in Clinical Pharmacy},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {24--33},
  doi = {10.59931/rcp.26.0005}
}
Kostenlos starten →